These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2242498)

  • 1. Calcitonin on osteoporotic bone fragility.
    Fujita T
    Calcif Tissue Int; 1990 Oct; 47(4):256. PubMed ID: 2242498
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of prolonged administration of porcine calcitonin in postmenopausal osteoporosis.
    Jowsey J; Riggs BL; Goldsmith RS; Kelly PJ; Arnaud CD
    J Clin Endocrinol Metab; 1971 Nov; 33(5):752-8. PubMed ID: 4942159
    [No Abstract]   [Full Text] [Related]  

  • 3. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intermittent treatment of Paget's disease of bone with calcitonin: histological study].
    Eisinger J; Laponche AM
    Rev Rhum Mal Osteoartic; 1976; 43(7-9):511-6. PubMed ID: 981933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is systemic treatment of osteoporosis and mandibular resorption possible?
    Driessens FC; Verbeeck RM; Van Dijk JW
    Acta Stomatol Belg; 1990 Jun; 87(2):107-24. PubMed ID: 2256451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic studies with porcine calcitonin in osteoporosis.
    Brown P; Thin CG; Malone DN; Roscoe P; Strong JA
    Scott Med J; 1970 Jun; 15(6):207-12. PubMed ID: 5427158
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcitonin and calcium combined therapy in osteoporosis: effects on vertebra trabecular bone density.
    Ozoran K; Paker N; Başgöze O; Hasçelik Z; Erzen C; Narman S; Ozker R
    J Int Med Res; 1989; 17(4):395-400. PubMed ID: 2792558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmon calcitonin in the treatment of postmenopausal osteoporosis.
    Fatourechi V; Heath H
    Ann Intern Med; 1987 Dec; 107(6):923-5. PubMed ID: 3318613
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of a one-year administration of phosphate and intermittent calcitonin on bone-forming and bone-resorbing cells in involutional osteoporosis: a histomorphometric study.
    Alexandre C; Chappard D; Caulin F; Bertrand A; Palle S; Riffat G
    Calcif Tissue Int; 1988 Jun; 42(6):345-50. PubMed ID: 3135102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis.
    Marie PJ; Caulin F
    Bone; 1986; 7(1):17-22. PubMed ID: 3964494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent acquisitions in therapy of osteoporosis of various etiologies with calcitonin].
    Vigo PL; Di Ciano L; Girardello R; Reschini E; Polli E
    Recenti Prog Med; 1977 Jun; 62(6):649-70. PubMed ID: 578332
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcitonin for the treatment of osteoporosis: dosage and dosing interval in Japan.
    Yamauchi H; Suzuki H; Orimo H
    J Bone Miner Metab; 2003; 21(4):198-204. PubMed ID: 12811623
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of thyrocalcitonin in osteogenesis].
    Briskin AI
    Ortop Travmatol Protez; 1973 Dec; 34(12):69-71. PubMed ID: 4790654
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of calcitonin replacement therapy in idiopathic juvenile osteoporosis.
    Jackson EC; Strife CF; Tsang RC; Marder HK
    Am J Dis Child; 1988 Nov; 142(11):1237-9. PubMed ID: 3177335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium and salmon calcitonin in treatment of osteoporosis.
    Jowsey J; Riggs BL; Kelly PJ; Hoffman DL
    J Clin Endocrinol Metab; 1978 Sep; 47(3):633-9. PubMed ID: 263316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-osteopenic effect of nasal salmon calcitonin in type 1 osteoporotic rats: comparison with subcutaneous dosing.
    Ichikawa M; Nakamuta H; Hoshino T; Ogawa Y; Koida M
    Biol Pharm Bull; 1994 Jul; 17(7):911-3. PubMed ID: 8000375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin therapy for bone disease and hypercalcemia.
    Avioli LV
    Arch Intern Med; 1982 Nov; 142(12):2076-9. PubMed ID: 7138154
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin.
    Kuntz D; Marie P; Berhel M; Caulin F
    Int J Clin Pharmacol Res; 1986; 6(2):157-62. PubMed ID: 3522444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New concepts in the treatment of osteoporosis.
    Jowsey J; Riggs BL; Kelly PJ
    Postgrad Med; 1972 Oct; 52(4):62-7. PubMed ID: 5070959
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthetic calcitonin for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 1985 Jun; 27(690):53-4. PubMed ID: 4000060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.